Charles Sinclair

5PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 05, 2022
A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerability.

Elizabeth A Kuczynski, Giulia Morlino, Alison Peter

|Jul 01, 2021
The future of immune checkpoint combinations with tumor-targeted small molecule drugs.

Jaclyn Sceneay, Charles Sinclair

|Sep 18, 2018
Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity.

Sophie Langdon, Adina Hughes, Molly A Taylor

|Aug 12, 2017
mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation.

Charles Sinclair, Gayathri Bommakanti, Luiz Gardinassi

Pageof 1